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Dietary trans-resveratrol (RES) is rapidly metabolized into sulfated and glucuronated conjugates in humans. This study focused on the in vitro determination
of the antioxidant capacity of RES and its main physiological metabolites and on its relevance in vivo. In vitro, RES, RES-3-O-sulfate (R3S) and 3-O-glucuronide
(R3G) showed antioxidant activities at a concentration of 1 mM when compared to Trolox using an assay in which the antioxidant inhibits iron-induced linoleic
acid oxidation: 0.87±0.08 mM Trolox equivalents (TE) for RES, 0.52±0.01 mM TE for R3S and 0.36±0.02 mM TE for R3G. At a concentration of 1 μM, compounds
promoted linoleic acid peroxidation (RES−0.30±0.09 mM TE, R3S−0.48±0.05 mM TE and R3G−0.57±0.07 mM TE). To elucidate whether these effects were
reflected in vivo, total antioxidant capacity, reactive oxygen species (ROS), conjugated fatty acid dienes (CD), superoxide dismutase (SOD) and catalase (CAT)
activities were determined in human plasma and erythrocytes over 24 h, after oral intake of either 0.05 g RES as piceid or 5 g RES. Oral administration of RES did
not show an impact on total antioxidant capacity, ROS or CD. However, enzymatic activities of ROS scavenging SOD and CAT were significantly lower after high-
dose compared to low-dose administration of RES (Pb.03 and Pb.01). In conclusion, in healthy subjects, neither 0.05 g nor 5 g RES changed blood oxidative state,
although our in vitro data point to a prooxidative activity of low concentrations of RES and its metabolites, which could be important in vivo for individuals with
compromised antioxidant defense capacity.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords: Resveratrol; Antioxidant capacity; ROS; SOD; CAT; Human1. Introduction
trans-Resveratrol (3,5,4′-trihydroxy-trans-stilbene, RES) is pre-
dominantly found in red grapes, peanuts or products thereof [1]. Upon
ingestion, RES and its predominant form in plant-derived foods, RES-
3-O-β-D-glycoside, termed piceid, are metabolized rapidly, forming
RES-sulfated and RES-glucuronated conjugates [2]. Depending on the
administered dose, plasma concentrations of RES metabolites vary
from nanomolar to micromolar range [2,3]. Quantitative data from a
previously conducted pharmacokinetic pilot study showedmaximum
plasma concentrations (cmax) of RES-3-O-sulfate (R3S), RES-disulfates
(RdS) and RES-monoglucuronides and diglucuronides of 0.95 μM,
1.27 μM and 0.7 μM, respectively, after a single oral dose of 85.5 mg⁎ Corresponding author. Tel.: +43-4277-70610; fax: +43-4277-9706.
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0955-2863/© 2015 The Authors. Published by Elsevier Inc. This is an open access article under tpiceid (corresponding to 0.05 g RES) [2]. Dietary administration of a
100-fold higher bolus dose of 5 g RES revealed cmax values for the
aforementioned metabolites of 81.3 μM, 28.2 μM and 67.6 μM,
respectively [3]. RES in plasma was below the limit of detection
(0.02 μM) after administration of 85.5 mg piceid and demonstrated a
cmax value of only 0.90 μM after administration of 5 g RES [2,3]. Both
conducted pharmacokinetic studies showed a low bioavailability for
RES in blood, in contrast to its metabolites, leading to the hypothesis
that the conjugates carry the biological activity in humans or are
reconverted into RES in target organs, as reported by Patel et al. [4].
Hence, reconversion data are still limited, and it seems conceivable
that observed health effects in humans can be attributed to RES
conjugates [5]. The effects of the parent compound RES on oxidative
and radical-scavenging mechanisms are controversially discussed [6].
Oxidative stress in form of reactive oxygen species (ROS) can lead to
modiﬁcation of proteins, lipids and carbohydrates and is hypothesized
to be associated with the progression of various pathological states,
e.g., cancer, age-related diseases and the development of type 2
diabetes [7,8]. In general, RES is known as a potent direct radical
scavenger and has been shown to interact with redox systems in vivo
by regulating antioxidant detoxiﬁcation enzymes like superoxide
dismutase (SOD), catalase (CAT) or glutathione peroxidase directly orhe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ever, Bader et al. [12] investigated the degradation of RES by γ-
radiation and hypothesized the formation of RES radicals in aqueous
solution as a result of OH-radical attack. Accordingly, at a considerably
low concentration of 8 μM, Ahmad et al. [13] could show that RES
induced a prooxidative state in human leukemia cells in vitro by
increasing intracellular superoxide by 25%, indicating a promoting
effect on radical formation. On the other hand, RES showed a direct
radical-scavenging effect in ratmacrophages in vitro at concentrations
ranging from 0.65 to 1.3 mM [14]. Furthermore, in human breast
cancer cells, Bader and Getoff [15] investigated the impact of 2 μMand
50 μM RES on the effectiveness of γ-ray irradiation on cell death in
vitro, and they could show that, at 2 μM, RES had a radical-scavenging
protective effect on cancer cells, whereas cancer cell death was
enhanced at 50 μM RES. Besides direct radical-scavenging activity,
another mechanism of action of RES is the up-regulation of ROS
detoxiﬁcation enzyme activity such as that of SOD and CAT. This was
shown by Mokni et al. [16] in an in vivo study of healthy rats after
intraperitoneal administration of 5–25 mg/kg body weight RES for
1 week, circumventing extensive metabolism in liver and digestive
tract. Considering aforementioned controversial ﬁndings, studies in
healthy human subjects after dietary relevant single dosage of RES
couldprovideuseful informationon the inﬂuence of this natural compound
and its metabolites on the natural balance of radical-scavenging systems
and are, to our knowledge, not yet available.We therefore initially assessed
the redox capacity of RES and its main physiological metabolites over a
wide range of concentrations (1–1000 μM) in a cell-free assay.
Consecutively, the current study aimed to compare the impact of a
RES-derivative piceid, present in plants, on the human blood antioxi-
dative capacity after a single low oral dose of 85.5 mg (0.05 g RES) [2],
representative for an average daily food intake fromdietary sources [1],
and a high oral amount of 5 g RES (10 capsules at 500 mg) [3],
representing commercially available nutritional supplements. Plasma
and erythrocyte samples were obtained from the pharmacokinetic
studies referenced above, conducted and published earlier, by Burkon et
al. [2] and Gualdoni et al. [3]. Formation of ROS, conjugated fatty acid
dienes (as a marker for radical induced lipid peroxidation, CD) and ROS
detoxifying enzyme activities (CAT and SOD) in human erythrocytes
were compared after single, differentially dosed, oral administration of
RES in healthy subjects to see if the obtained in vitro results were
reﬂected in the redox status of human blood.Measurementswere done
in a timelymanner after blood drawings, and as of now,we could show
for the ﬁrst time a dose-dependent impact of oral short-term
administration of RESonantioxidative enzymeactivities in erythrocytes
of healthy subjects.2. Materials and methods
2.1. Chemicals
The reagents and solvents used for the experiments were purchased from Sigma-
Aldrich (Taufkirchen, Germany) and Merck (Darmstadt, Germany). The SOD assay kits
used for the activitymeasurementswere acquired fromDojindo (Gaithersburg,MD, USA).
Benzoyl-leucomethylene blue was purchased from TCI Germany (Eschborn, Germany).2.2. Plasma and erythrocyte samples
The plasma and erythrocyte samples were obtained from two human intervention
studies, as reported by Burkon et al. (n=9) [2] and Gualdoni et al. (n=8) [3] on the
pharmacokinetics of RES andmetabolites, both ofwhichwere performed and published
earlier [2,3]. After drawing blood samples as references, a single oral dose of either
85.5 mg piceid (corresponding to 0.05 g trans-RES) per 70 kg body weight (Burkon et
al. [2]) or an absolute amount of 5 g of RES (Gualdoni et al. [3]) was administered. After
oral administration, blood samples were drawn over 24 h (piceid) and 48 h (5 g RES),
immediately separated into plasma and erythrocytes by centrifugation, washed three
times with 0.9% sodium chloride solution and stored at −80°C, shortly followed by
further analyses.2.3. Total antioxidative activity
Total antioxidative activity was determined following the procedure reported by
Lindenmeier et al. that is based on the inhibition or promotion of the iron-catalyzed
peroxidation of linoleic acid by added antioxidants [17]. Initially, the total antioxidant
activity of RES and the RES metabolites was measured. R3S, RdS and 3-O-glucuronide
(R3G) were synthesized and puriﬁed as published previously [2]. Solutions of each
substance (1–1000 μM in 15% aqueous ethanol) were prepared and aliquots (50 μl) of
these solutionswere used for testing. For the determination of the antioxidative activity
of plasma samples, these were spiked with ethanol for a ﬁnal concentration of 15%
ethanol and aliquots (50 μl) were used for testing. The antioxidative activity was
correlated with the degree of color development (conversion of benzoyl-leucomethylene
blue to methylene blue), which was measured at 666 nm in disposable cuvettes on a
TecanInﬁnite 200 (Groedig, Austria). Results were calculated using a seven-point-
calibration curvewith Trolox solutions as reference antioxidant (0–2 mM in 15% aqueous
ethanol) and the total antioxidative activity was expressed as Trolox equivalents (TE)
(mmol/L). Experiments were performed in triplicates, with two technical replicates.
2.4. Determination of total ROS in erythrocytes
Total ROS was determined by FACS measurement according to Amer et al. [18]. It is
based on the uptake of nonﬂuorescent 2′,7′-dichloro-ﬂuorescin-diacetate (DCF-DA)
into cells and its conversion to 2′,7′-dichloro-ﬂuorescin (DCFH) by endogenous
esterases. ROS-containing cells convert DCFH to a ﬂuorescent 2′,7′-dichloro-ﬂuorescein
(DCF) radical, with absorption maximum at 488 nm. A 1:20 dilution of erythrocytes in
PBS was incubated for 15 min (37°C, 5% CO2) with 0.4 mM DCF-DA, centrifuged and
washed oncewith 1 ml of PBS. Subsequently, an aliquotwas incubatedwith 2 mMH2O2
for 30 min at room temperature. Measurement of 100,000 cells was performed with a
FACSCalibur (Becton-Dickinson, New Jersey, USA). The difference between ﬂuorescent
values of H2O2-stimulated and nonstimulated cells was normalized to hemoglobin
content of the sample, and data were then calculated in percent as treated (n=8) over
control (n=2).
2.5. Measurement of CD in erythrocytes
The lipid extraction from the erythrocytes was carried out by a modiﬁed method
reported by Folch et al. [19], followed by saponiﬁcation and methylation of the fatty
acids according to the Association of Ofﬁcial Analytical Chemists method [20]. A volume
of 10 μl of this fatty acid composition was injected into an HPLC column and CD were
quantiﬁed using diode array detection (DAD) at a wavelength λ=234 nm. Separation
was performed on a Dionex Ultimate 3000 LC system (Thermo Fisher Scientiﬁc, Vienna,
Austria), using a Nucleosil 100-5 C18 analytical HPLC column (250×4.6 mm ID, 5 μm
particle size;Macherey-Nagel, Düren, Germany)with a precolumnof the samematerial,
at a ﬂow rate of 0.8 ml/min at 25°C. Liquid chromatography was carried out using the
following conditions: starting with 95% acidiﬁed H2O bidest (0.1% formic acid) and 5%
acidiﬁed acetonitrile (0.1% formic acid), the acetonitrile content was increased to 80%
within 20 min then to 100% within 25 min and was maintained for 5 min. Thereafter,
the columnwas reset to the initial conditions within 5 min and equilibrated for another
5 min. Each of the experiments was performed in triplicates. CD content was deﬁned as
the area under the curve (AUC) related to the content of total lipids extracted via the
Folch extraction [19]. The total lipid content was determined by a photometric assay
according to the manufacturers’ protocol (Randox Laboratories, Krefeld, Germany).
2.6. Measurement of SOD activity in erythrocytes
The SOD activity in erythrocyteswas determined by the SOD assay kitwater-soluble
tetrazolium salt, according to the manufacturers’ protocol (Dojindo, Gaithersburg, MD,
USA) with slight modiﬁcations. For sample preparation, 0.5 ml of erythrocytes was
suspended with 2 ml of distilled water then 1 ml of ethanol and 0.6 ml of chloroform
were added and the mixture was shaken vigorously with a shaker for 15 min at 4°C.
Afterwards, the mixture was centrifuged at 600g for 10 min at 4°C, the upper water/
ethanol phase was transferred into a new tube and diluted 1:8 with distilled water. To
achieve the sample solution for the assay, a ﬁnal dilution step was accomplished with
0.25% aqueous ethanol. In the SOD assay, a highly water soluble tetrazolium salt (WST-
1) was used, which was converted to a water-soluble formazan dye through reduction
by superoxide anions. The rate of reduction of the superoxide anions was linearly
related to the xanthine oxidase activity and inhibited by SOD (sample solution). Thus,
the SOD activity (50% inhibition) was determined colorimetrically in duplicates in 96-
wellmicroplates at awavelengthλ=450 nm. Finally, the SOD activitywas related to the
hemoglobin content of the sample.
2.7. Measurement of CAT activity in erythrocytes
The CAT activity in erythrocytes was determined following a photometric assay
reported by Aebi [21]. For sample preparation, erythrocytes were diluted 1:5 with
distilled water. A further 1:500 dilution step was performed with phosphate buffer
immediately before the assay was started by adding H2O2. The determination was
performed in duplicates and the decrease of H2O2 absorbance was recorded at 240 nm
for 30 s (at 20°C) in disposable cuvettes. Results were calculated and demonstrated as
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hemoglobin content of the sample.
2.8. Hemoglobin content in erythrocytes
The hemoglobin content in erythrocytes was determined following a method with
Drabkin’s reagent according to the manufacturers’ protocol (Sigma-Aldrich, Taufkirchen,
Germany) with slight modiﬁcations. For sample preparation, the erythrocytes were diluted
1:2 with distilled water and aliquots (20 μl) were used in the colorimetric assay. The
determination was performed in duplicates and the absorbance was recorded at a
wavelength λ=540 nm. Finally, the results were calculated using a ﬁve-point-calibration
curve with human hemoglobin solutions as standards (0.15–0.92 mg/ml in distilled water).
2.9. Statistical analysis
All data presented are expressed as means±S.E.M. The differences in the enzyme
activities and the oxidative exposure of erythrocytes (CD) between time point 0 h and
the various time points after administration of piceid and RES were calculated using
two-tailed Student’s t test for nonpaired samples. The same testwas used for calculation
of differences between high-dose and low-dose administrations of RES, using AUC
values. P≤.05 was considered signiﬁcant.
3. Results and Discussion
3.1. Total antioxidative capacity in vitro
The antioxidative activity of RES and its main physiological
metabolites (R3S, RdS and R3G) was measured following a protocol
by Lindenmeier et al. [17]. This method is based on the Fenton-type
reaction, with linoleic acid as a substrate for iron-catalyzed radical
attack by H2O2-derived OH− radicals. Resulting linoleic acid peroxides
then catalyze the conversion of colorless benzoyl-leucomethylene
blue to methylene blue, which absorbs at 666 nm. Addition of a given
substance can either inhibit (antioxidative) or promote (prooxidative)
linoleic acid peroxidation, resulting in differential color development
[22,23]. Results were calculated using an eight-point Trolox calibra-
tion curve (0–2 mmol/L, R2=0.995). RES, R3S, RdS and R3G at
concentrations 1, 10 and 100 μM showed a promoting effect on
linoleic acid peroxidation, with lowest TE values (mM TE) of−0.30±
0.09 mM TE, −0.48±0.05 mM TE, −0.36±0.09 mM TE and −0.57±
0.07 mM TE, respectively, at a concentration of 1 μM (Fig. 1). At
100 μM, the parent compound showed an inhibiting effect on linoleic
acid peroxide formation, compared to the metabolites, which still
induced peroxidation. Whereas at 1000 μM, the antioxidative activity
of RES resulted in 0.87±0.08 mM TE, values for the metabolites were
lower with 0.52±0.01 mM TE for R3S and 0.36±0.02 mM TE for R3G.
No effect with respect to total antioxidant capacity was observed forFig. 1. In vitro total antioxidant activity of RES and its main physiological metabolites
R3S, RdS and R3G in aqueous solution (in mM TE); concentration-dependent effects for
individual compounds are indicated by lowercase letters as determined by ANOVA,
followed by post hoc Holm-Sidak testing (P≤.05); data are expressed as means±S.E.M.
(n=3–6).RdS at 1000 μM. These results clearly demonstrate that the redox
capacity of RES and its conjugates varied dose dependently from 1 μM
to 1000 μM from prooxidant to antioxidant in our cell-free assay. On
the one hand, the linoleic acid peroxidation inducing effect of low
concentrations of RES corresponds to in vitro ﬁndings byMartins et al.,
where RES, at concentrations of 1–50 μM, increased ROS levels in
hepatic cells after a 24 h treatment [24]. On the other hand, a decrease
in superoxide anionproduction could be shownat only 3 and6 μMRES
in vitro, however in a model of hyperglycemic THP-1 monocytes to
mimic diabetes, with higher levels of oxidative stress to begin with
[25]. In our cell-free study, at a concentration of 100 μM, RES is more
antioxidatively active than its metabolites R3S, RdS and R3G (ANOVA,
post hoc Holm-Sidak, P≤.007). At 1000 μM, RES inhibits linoleic acid
peroxidation more effectively than R3S and R3G (ANOVA, post hoc
Holm-Sidak, P≤.003). This could be due to the conjugation of 3-
hydroxy and 5-hydroxy groups, which was shown to impair the
thermodynamic stabilization of the radical-scavenging system of RES
[26]. The potential of free RES to inhibit linoleic acid peroxidation at
concentrations of 100 and 1000 μM, compared to RES conjugates, is
further conﬁrmed by Storniolo et al., where at 50 μM, activity of RES
was more profound than that of R3S or R3G [27].
3.2. Oxidative status in vivo
3.2.1. Total antioxidant capacity in plasma
In a study by Olas et al. [28], a pronounced protective effect against
the ROS species peroxynitrite could be shown in plasma of healthy
volunteers for 100 μM RES. Therefore, after determining the antiox-
idant effect of RES and its conjugates on the iron-induced linoleic acid
peroxidation in vitro, we analyzed the redox status in plasma of
healthy subjects after oral administration of 0.05 g RES, in form of
85.5 mg piceid by means of the in vitro applied test (Table 1) [17].
Contrary to our in vitro ﬁndings at 1 μM, at cmax values of 0.95 μM,
1.27 μM and 0.7 μM, for R3S, RdS and RES-glucuronides, respectively,
as determined earlier by Burkon et al. [2] for the same study
population, no changes compared to basal levels (t0, set at 100%)
were observed in vivo. The absence of anymeasurable effect of RES and
metabolites in vivo might be explained by the higher abundancies of
other antioxidants present, such as ascorbic acid, tocopherol, retinol or
glutathione [29].
3.2.2. Total ROS in erythrocytes
The in vitro observed prooxidative effect of RES and its conjugates
was not reﬂected in vivo by the total antioxidant activity in plasma
after administration of 85.5 mg piceid (0.05 g RES). Therefore, the
effects of RES and its metabolites on nonenzymatic and more speciﬁc
markers of oxidative stress (ROS and CD) were determined in
erythrocytes after a high oral load of 5 g. Levels of ROS in erythrocytes
were determined by the intracellular conversion of DCFH to a DCF
radical andwere calculated as treated (n=8) over control (n=2),with
time point t0 set at 100% as baseline value, as depicted in Fig. 2. NoTable 1
Total antioxidant activity in human plasma after the administration of a single dose of
85.5 mg piceid per 70 kg body weight (n=9); time point 0 h (t0) was set as 100%, and
data represent means±S.E.M.









Fig. 3. CD in human erythrocytes after the administration of (A) single-dose piceid
(0.05 g RES, n=9) and (B) single-amount RES (5 g, n=8); results are normalized to
total lipid content and t0 was set as 100%; data represent means±S.E.M.; a two-tailed
Student’s t test for nonpaired samples was applied to calculate differences between
time points, and P≤.05 was considered signiﬁcant.
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ofmetabolized RES on ROS formation in erythrocytes. After an amount
of 5 g RES, cmax values in plasma were 0.09 μM, 81.3 μM, 28.2 μM and
67.6 μM, at timepoints (tmax) 2.5 h, 5 h, 10 h and2.5–5 h, for RES, R3S,
RdS and RES-glucuronides, respectively, as reported by Gualdoni et al.
[3]. According to our here-presented results on ROS formation in
human erythrocytes, those concentrations are apparently not relevant
for an antioxidant effect. On the other hand, we could not observe a
prooxidant effect either, as suggested by our in vitro data (Fig. 1),
although ROS values show an increase from 5 to 10 h (Fig. 2). This
interval corresponds approximately to cmax for metabolites, namely
R3S and the RES-4′-O-glucuronide with tmax at 5 h and RdS with tmax
at 10 h after oral administration, as previously determined by
Gualdoni et al. [3]. However, it should be mentioned that, in vitro, at
a concentration of 100 μM, we could observe a radical inducing effect
for RES conjugates, with values for predominating metabolites R3S
and R3G of −0.12±0.04 and −0.09±0.01 mM TE, whereas in an in
vitro study by Storniolo et al. [27], 50 μMof the respective compounds
showed a radial-scavenging effect of 0.11±0.02 and 0.12±0.03 mM
TE. In the referenced study, results were also compared to TE but
achieved by means of a commercially available kit, based on the
inhibition of the oxidation of 2,2′-azino-di-[3-ethylbenzthiazoline
sulfonate] (ABTS) to ABTS+ by present compounds [30]. As evaluated
by Tabart et al. [31], total antioxidant values can vastly differ for
individual compounds, depending on the applied test. Measuring the
scavenging activity of the 2,2-diphenyl-1-picrylhydrazil radical and
measuring the oxygen radical-scavenging capacity, for example,
showed distinct differences in antioxidant capacities for selected
ﬂavonoids due to different reaction mechanisms [31]. We therefore
estimate the impact of predominant RES conjugates on ROS levels in
concentrations up to approximately 100 μM in human erythrocytes to
be negligible, especially, as other antioxidants very likely cover their
effect due to higher molar abundances [29].
3.2.3. CD in erythrocytes
To examine whether the metabolites formed in vivo after oral
intake of 0.05 g or 5 g RES affected the oxidative exposure of
erythrocytes, CD were quantiﬁed in erythrocytes by HPLC DAD
(Fig. 3). As CD are more stable than ROS, these oxidized fatty acids
can be used to determine changes in erythrocyte redox state that
would be overseen due to short half-life of ROS, in combination with
the time periods between blooddrawings. In accordancewith our dataFig. 2. ROS levels in erythrocytes, as determined by DCF ﬂuorescence; values are
normalized to hemoglobin content and calculated as treated (n=8) over control group
(n=2) with baseline at time point t0 set at 100%; data represent means±S.E.M.; a two-
tailed Student’s t test for nonpaired samples was applied to calculate differences
between time points, and P≤.05 was considered signiﬁcant.on antioxidant capacity and ROS, no changes to baseline values (100%)
could be determined at anymeasured time point. Comparison of AUCs
(in arbitrary units, a.u.) between dietary low RES (AUC0.05 g=2260±
76.8 a.u.) and high RES, after a 5 g supplement (AUC5 g=2018±
156 a.u.) showed no signiﬁcant difference for CD in erythrocytes,
although Fig. 3B showed a decrease in CD levels in the ﬁrst 5 h, which
would indicate an antioxidant effect. This potential antioxidant effect
is in agreement with other studies where incubation of erythrocytes
with 0.1–100 μM RES attenuated oxidative-injured erythrocyte
membrane in vitro [32,33]. A dose-dependent decrease of tert-
butylhydroperoxide-induced formation of malondialdehyde was
obtained after treatment of the erythrocytes with RES. However, in
the current study, no changes in CD levels were determined after a
dose of only 0.05 g RES (Fig. 3A).3.2.4. Antioxidant enzyme activities in erythrocytes
The function of antioxidant enzymes (SOD, CAT, glutathione
peroxidase) in blood and tissues is to protect from ROS-mediated
damage [34]. Down-regulation of gene transcripts and the activity of
those enzymes have been linked with increased amounts of ROS and
cause increased susceptibility to oxidative damage [35,36]. As
erythrocytes are not able to transcribe and translate genes, antioxidant
enzyme activitiesweremeasured in red blood cells of participants, as a
marker for oxidative stress.
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detoxifying enzymes, SOD and CAT activity in erythrocytes was
determined after oral administration of different amounts of RES over
24 h (Figs. 4 and 5). No differences compared to basal levels could be
observed after administration of either 0.05 g or 5 g RES. However, by
comparison of AUC values of the SOD activity in both studies, SOD
activity was reduced after intake of 5 g RES compared to the low-dose
intake of 0.05 g RES in form of piceid (AUC0.05 g=2365±43.0 a.u. and
AUC5 g=1829±216 a.u., P=.03). This effect of the higher oral amount
of RES might be at least partially explained by lower values at 2.5 h
after administration of 5 g RES (Fig. 4B), corresponding to the time
points for cmax of glucuronatedmetabolites (total of 67.6 μM), ranging
from 2.5 to 5 h, as documented by Gualdoni et al. [3], and could
indicate changes in erythrocyte oxidative state, whichmight not occur
with low-dose RES, where cmax for glucuronides was only 0.7 μMwith
tmax at 6 h after ingestion [2].
3.2.4.2. CAT in erythrocytes. As for SOD, no differences to basal levels
could be observed for CAT activity in either group, but again, a lower
enzymeactivity could bedemonstrated for the high amount RES group
by AUC comparison to the low-dose RES group (AUC0.05 g=2373±
119 a.u. and AUC5 g=1411±230 a.u., P=.01, Fig. 5). For the parent
compound RES, an enzyme inhibiting effect on CAT has been observed
by Martins et al. [24], at 50 μM in vitro in liver cells. As the parent
compound is not present in plasma in such high concentrationsFig. 4. SOD activity in human erythrocytes, normalized to hemoglobin content after the
administration of (A) single-dose piceid (0.05 g RES, n=9) and (B) single-amount RES
(5 g, n=8); t0 was set as 100%; data represent means±S.E.M.; a two-tailed Student’s t
test for nonpaired samples was applied to calculate differences between time points,
and P≤.05 was considered signiﬁcant.
Fig. 5. CAT activity in human erythrocytes normalized to hemoglobin content after the
administration of (A) single-dose piceid (0.05 g RES, n=9) and (B) single-amount RES
(5 g, n=8); t0 was set as 100%; data represent means±S.E.M.; a two-tailed Student’s t
test for nonpaired samples was applied to calculate differences between time points,
and P≤.05 was considered signiﬁcant.(cmax=0.09 μM) after oral administration of 5 g RES, those changes in
enzyme activity could be attributed to the main conjugates. Fig. 5B
shows a trend for lower enzyme activities, albeit not reaching the level
of signiﬁcance (P=.063), CAT activity at 2.5 h (tmax of glucuronide
conjugates) and additionally from 5 h to 24 h, corresponding to tmax
after oral administration for R3S at 5 h (cmax=81.3 μM) and for RdS at
10 h (cmax=28.2 μM), as determined by Gualdoni et al. [3].
4. Conclusions
Oral administration of RES did not affect the iron-catalyzed linoleic
acid peroxidation and ROS formation in human erythrocytes,
presumably due to the presence of more potent antioxidants [29]
and the comparably low concentrations of RESmetabolites (cmax from
0.27 to 1.27 μMafter oral intake of 0.05 g RES and from28.2 to 81.3 μM
after 5 g RES) [2,3]. Moreover, the high-plasma-protein binding
capacity of RES and its metabolites of over 93% for RES, 66% for R3S
and 56% for RdS might also impede their effect on ROS formation [2].
However, our data suggest a prooxidative effect of orally ingested RES
as demonstrated by decreased SOD and CAT activity in erythrocytes,
after administration of a high bolus dose of 5 g RES, compared to low-
dose administration as 85.5 mg piceid, especially at time points
corresponding to maximum plasma concentrations of individual
metabolites (cmax for glucuronides being 67.6 μM with tmax at 2.5 h
and 81.3 μM for R3S with tmax at 5 h after 5 g RES intake). Down-
169M. Pignitter et al. / Journal of Nutritional Biochemistry 27 (2016) 164–170regulation of SOD and CAT activity has been associated with an
increased ROS formation [35,36], which was most likely compensated
by the presence of other antioxidants in our in vivo studies. In our in
vitro assay, antioxidant activities were demonstrated for concentra-
tions of 100 μM, which were not reached even after the bolus dose of
5 g RES, resulting in ameanmaximumplasma concentration for the 3-
O-sulfated metabolite of 81.3 μM, followed by RES glucuronides with
67.6 μM [3]. Additionally, plasma half lives in humans for RES
conjugates were determined to be only 5–8 h, after an oral dose of
5 g, resulting in rapid elimination from the body [37]. In accordance
with our in vitro data, at concentrations of 1 and 10 μM, Ahmad et al.
[13] demonstrated that treatment with 4–8 μM RES for 24 h
profoundly increased intracellular radical concentrations (up to 25%)
in human leukemia cells and even showed an interference with
chemotherapeutic-induced apoptosis. Our in vitro data indicate that
the major RES metabolites have a similar potential on radical
formation. Considering the antioxidant effect of higher concentrations
of RES and its metabolites, blood or tissue accumulation resulting in
higher steady-state concentrations of RES could have not been
reported in healthy human subjects so far, as demonstrated by
Almeida et al. [38]. Here, a mean cmax value in plasma was only
0.28 μMand half-life of RESwas determined to be 2–5 h after intake of
4× 150 mg RES over 24 h. Accordingly, after oral intake of 1 g RES
administered twice a day for a week to healthy human subjects, a
mean cmax value in plasmawas 5.58 μM, and half-lifewas 2.4 h [39]. In
one of our conducted pharmacokinetic studies, intake of 85.5 mg
piceid led to plasma metabolite concentrations below 1.27 μM (RdS),
and in line with their short elimination half-lives and our herein
obtained data, we conclude that dietary ingested amounts of RES or
piceid do not signiﬁcantly inﬂuence the redox balance in blood
samples of healthy subjects [2]. Taken together, even with single oral
administration of RES in a dose corresponding to a high-dose
nutritional supplementation, it seems unlikely to achieve plasma
concentrations high enough for antioxidative effects in healthy
subjects as observed in our in vitro experiments. However, Brasnyó
et al. [40] showed a decrease of oxidative stress in urine of type 2
diabetic patients, after only 5 mg oral RES twice daily for 4 weeks. It
has to be considered, though, that type 2 diabetics have higher basal
systemic oxidative stress levels than metabolically healthy subjects
and endogenous cellular stress response is attenuated, possibly
featuring the effects of administered xenobiotics [41,42]. In conclu-
sion, further investigations on the short-term and long-term dose-
dependent effects of RES on blood and tissue redox mechanisms and
enzymes especially in patientswith compromised antioxidant defense
capacity are needed to determine its antioxidant potential in disease.
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